Literature DB >> 2107131

Medicaid spenddown in nursing homes.

K Liu1, P Doty, K Manton.   

Abstract

This paper employs information from nationally representative surveys to examine the incidence and causes of Medicaid spenddown among disabled elderly persons. About 10% of nursing home discharges experience "asset spenddown," the process of converting from private pay to Medicaid. In contrast, over 50% of nursing home patients remain private pay throughout their stays. In addition, becoming a Medicaid patient is more common among community residents than among nursing home residents. Implications of findings for health care policies are discussed.

Entities:  

Mesh:

Year:  1990        PMID: 2107131     DOI: 10.1093/geront/30.1.7

Source DB:  PubMed          Journal:  Gerontologist        ISSN: 0016-9013


  5 in total

1.  Higher Medicare SNF care utilization by dual-eligible beneficiaries: can Medicaid long-term care policies be the answer?

Authors:  Momotazur Rahman; Denise Tyler; Kali S Thomas; David C Grabowski; Vincent Mor
Journal:  Health Serv Res       Date:  2014-07-22       Impact factor: 3.402

2.  Are dual eligibles admitted to poorer quality skilled nursing facilities?

Authors:  Momotazur Rahman; David C Grabowski; Pedro L Gozalo; Kali S Thomas; Vincent Mor
Journal:  Health Serv Res       Date:  2013-12-19       Impact factor: 3.402

3.  Factors affecting conversion rates to Medicaid among new admissions to nursing homes.

Authors:  V Mor; O Intrator; L Laliberte
Journal:  Health Serv Res       Date:  1993-04       Impact factor: 3.402

Review 4.  Mapping the Global Landscape of Long-Term Care Insurance Research: A Scientometric Analysis.

Authors:  Long Xia; Lulu Chai; Hanyu Zhang; Zhaohui Sun
Journal:  Int J Environ Res Public Health       Date:  2022-06-17       Impact factor: 4.614

5.  Dual Eligibility, Selection of Skilled Nursing Facility, and Length of Medicare Paid Postacute Stay.

Authors:  Momotazur Rahman; Pedro Gozalo; Denise Tyler; David C Grabowski; Amal Trivedi; Vincent Mor
Journal:  Med Care Res Rev       Date:  2014-05-14       Impact factor: 3.929

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.